If you have a question for our guest, host or DRG please submit it here.
COVID-19 continues to disrupt patient care
Guest: John Jaeger, Partner, Decision Resources Group
In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership talks to John Jaeger, a partner at DRG on how COVID-19 is disrupting access to care. John talks us through the results from a recent physician survey, about current limitations on access to treatment including how patients are responding to the shift from in-facility treatment to home-administered treatments. John and Mike also discuss the implications of the “warehousing” effect that will take place and continue to disrupt the space caused by patients waiting to receive care or delaying treatment until the pandemic eases. They also speculate which of these changes may become permanent fixtures post pandemic. Watch now to learn more.
About our Guest
John Jaeger, Partner, Decision Resources Group
John Jaeger leads DRG Consulting’s US Market Access Practice and is a commercial strategy consultant focused on US pricing, reimbursement, and market access. John has a strong interest and focus in partnering with the life sciences industry to develop innovative solutions focused on optimizing patient access, improving customer engagement, and ensuring successful market entry. For over 15 years, John has worked across the US healthcare landscape on a variety of topics including value proposition development, product launch, portfolio and life-cycle management, pricing and contract strategy, and regional influence mapping.
About our Host
Mike Ward, Head of Thought Leadership, DRG
Mike Ward serves as Global Head of Thought Leadership at Decision Resources Group (DRG), part of Clarivate. As both a journalist and analyst, Mike has been writing, analyzing and commenting on the life sciences industry for more than 35 years. He has held editorial and content leadership roles at various publications and organizations across the industry.